Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Hormone Receptor Positive (HR+), HER2-negative Breast Cancer|Biopsy-proven, Positive Lymph Node(s)
Interventions: RADIATION: Radiation Therapy Boost|DRUG: Pembrolizumab|DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: Cyclophosphamide|DRUG: Doxorubicin|DRUG: Capecitabine
Sponsor: Laura M. Spring, MD
Collaborators: Merck Sharp & Dohme LLC|Breast Cancer Research Foundation|Translational Breast Cancer Research Consortium